SCHEMBL1038153

SCHEMBL1038153

Cc1ccc(C(=O)P(=O)(CC(C)CC(C)(C)C)C(=O)c2c(C)cc(C)cc2C)c(C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.34
HTT P42858 1/20 0.34
TAS1R3 Q7RTX0 1/20 0.34
TAS1R1 Q7RTX1 1/20 0.34
TAS1R2 Q8TE23 1/20 0.34
HPGD P15428 2/20 0.33
KMT2A Q03164 2/20 0.33
LMNA P02545 2/20 0.33
MEN1 O00255 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
MCOLN3 Q8TDD5 1/20 0.33
NPC1 O15118 4/20 0.32
RAB9A P51151 3/20 0.32
ALDH1A1 P00352 1/20 0.32
HSD11B1 P28845 1/20 0.32
KDM4E B2RXH2 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
CACNA1B Q00975 1/20 0.31
UTS2R Q9UKP6 1/20 0.31
POLB P06746 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL611535 0.90 L3MBTL1 (0.36) SMN1; SMN2TAS1R3TAS1R1TAS1R2HPGD
SCHEMBL5996661 0.86 LMNA (0.34) SMN1; SMN2HPGDKMT2ALMNAMEN1
SCHEMBL5995314 0.85 KDM4E (0.33) SMN1; SMN2HPGDKMT2ALMNAMEN1
SCHEMBL14641678 0.83 KDM4E (0.37) SMN1; SMN2HPGDKMT2ALMNAMEN1
SCHEMBL5997895 0.83 TP53 (0.42) SMN1; SMN2HTTHPGDKMT2ALMNA
SCHEMBL5993788 0.82 MEN1 (0.36) HTTKMT2ALMNAMEN1RAB9A
SCHEMBL5997227 0.82 LMNA (0.34) SMN1; SMN2HPGDKMT2ALMNAMEN1
SCHEMBL5995206 0.81 L3MBTL1 (0.34) HTTKMT2AMEN1KDM4EL3MBTL1
SCHEMBL5995257 0.81 TAS1R3 (0.34) SMN1; SMN2TAS1R3TAS1R1LMNAALDH1A1
SCHEMBL5997774 0.81 HMGCR (0.32) HPGDRAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1814891-B1 BISACYLPHOSPHANES AND THEIR USE AS PHOTOINITIATORS; PROCESS FOR PREPARING ACYLPHOSPHANES BASF SE (DE) 2011-01-26 EP disclosed
US-7687657-B2 Process for preparing acylphosphanes and derivatives thereof CIBA SPECIALITY CHEMICALS CORPORATION (US) 2010-03-30 US disclosed
US-20080004464-A1 Process for Preparing Acylphosphanes and Derivatives Thereof IGM GROUP B.V. (NL) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004464-A1 Process for Preparing Acylphosphanes and Derivatives Thereof ME2, ME3, MEP1A SMN1; SMN2 3557/4885HTT 4242/4885TAS1R3 1630/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.